About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
https://www.soho2019.com/
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Ph+ ALL: How Can We Optimize Treatment for All Patients Through Better Molecular Stratification and Better Therapeutic Management (TKIs +/- Chemo, CAR-T)?
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Sabina Chiaretti
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Sabina Chiaretti
6 views
October 17, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Acute Lymphoblastic Leukemia
14:35
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Moving Beyond Single Antigen CAR-T Targeting in ALL: Current Status …
Feat.
N. Shah
12:05
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Is HCT Still Needed in the Era of Targeted Cellular Therapies for Ac…
Feat.
P. Kebriaei
14:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Is HCT Still Necessary in the Era of Targeted Cellular Therapy for A…
Feat.
M. Pulsipher
14:38
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Combining Genotype Profiling with MRD for More Accurate Prognosticat…
Feat.
J. Bartram
15:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Ph+ ALL: How Can We Optimize Treatment for All Patients Through Bett…
Feat.
S. Chiaretti
04:11
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Management of Adult ALL: Which Chemo Intensity, Further Progress Wit…
Feat.
D. Hoelzer
12:37
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Novel Therapies in Older Patients with Ph- B-Cell ALL: Older ALL, Po…
Feat.
E. Jabbour
14:53
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
The Challenge of Improving Outcomes for ETP ALL and Relapsed Disease…
Feat.
B. Shah
09:16
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Duplex Sequencing Identifies Low Level ABL1 Kinase Domain Mutations …
Feat.
N. Short
07:55
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
More or Less? Impact of Dose Number on Outcomes of Patients w/ ALL T…
Feat.
E. Jabbour
